Direct costs associated with a hospital-acquired outbreak of rotaviral gastroenteritis infection in a long term care institution

Piednoir, E.; Borderan, Guy-Claude; Borgey, F.; Thibon, Pascal; Lesellier, P.; Leservoisier, R.; Verger, P; Coutour, X. Le

doi:10.1016/j.jhin.2010.03.024

Cited by 8 publications

(10 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Findings in this study should be interpreted with caution. First, albeit consistent with most studies in the literature [ 12 , 14 , 15 , 18 , 19 , 22 – 24 ], data used in this study came from one hospital and the results were not representative of other hospitals in Thailand. Nevertheless, it was not possible to undertake costing at the national level since there was no database on hospital resources used for COVID-19 in the country.…”

Section: Discussionsupporting

confidence: 66%

“…In other words, the former was a direct function of the number of COVID cases (confirmed or otherwise) received by the hospital, while the latter was not. The distinction between direct and indirect costs here should not be confused with alternative definitions in existing studies [ 10 , 12 , 22 ], where the term ‘indirect costs’ may refer to productivity loss during an outbreak. Panel E corresponds closely to Panel B.…”

Section: Resultsmentioning

confidence: 99%

“…Consistent with the literature, this study showed that, to measure the financial impact of an outbreak, costs of both treatment and infection control needed to be accounted for. Existing studies on hospital-level costing demonstrated the importance of infection control activities among medical personnel [ 13 ] as well as intra-ward [ 14 , 18 , 22 ] and hospital-wide [ 12 , 15 , 16 , 19 , 23 – 25 ] infection control measures during outbreaks. With some exceptions [ 13 , 16 , 19 ], treatment costs were usually covered.…”

Section: Discussionmentioning

confidence: 99%

“…With some exceptions [ 13 , 16 , 19 ], treatment costs were usually covered. Most studies performed micro-costing and reported per-patient costs, using data from either one hospital [ 12 , 14 , 15 , 18 , 19 , 22 – 24 ] or a selected group of hospitals [ 9 ], while others relied on cost and charge data from a national database [ 10 , 11 ]. Nevertheless, results varied and were not directly comparable, as the setting and the context of the outbreak differed across studies.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Cost analysis of a teaching hospital in Thailand: Impacts of the first wave of COVID-19

2022

View full text Add to dashboard Cite

COVID-19 has had adverse impacts on the health sector in Thailand and information on hospital costs is required for planning and budgeting. The aim of this study was to estimate costs that the pandemic imposed on a teaching hospital in the country, focusing on the first wave which took place in March-May 2020. A retrospective cost analysis was performed. Data on COVID-related activities, including when and where they were undertaken, were retrieved from existing sources and supplemented by in-depth interviews with the hospital’s staff. The data collection period was January-October 2020, covering three distinct phases: before, during, and after the first wave of the pandemic. The total costs during the preparation phase in January-February, the pandemic phase in March-May, and the standby phase in June-October were 0.6, 3.9, and 1.2 million US dollars respectively. Costs related to treatment of COVID-19 patients were higher than those related to infection control in the first two phases but not in the standby phase, making up 82.09%, 75.23%, and 43.95% of the total costs in the three phases respectively. Costs were incurred in all areas of the hospital, including those that were set up to serve COVID patients, those serving non-COVID patients, and those serving both groups. Public donations were integral to the provision of services and made up 20.94% of the total cost during the pandemic phase. This study was the first to estimate hospital costs of COVID-19 in Thailand. It demonstrated high costs of a national outbreak and supported the establishment of a contingency fund for medical emergencies at the hospital level.

show abstract

Section: Discussionsupporting

confidence: 66%

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Cost analysis of a teaching hospital in Thailand: Impacts of the first wave of COVID-19

2022

View full text Add to dashboard Cite

show abstract

“…More than 80% of facilities have infection prevention manuals, have taken steps to educate and ensure that their staff are aware of the content of these manuals, and have established infectious disease response committees [6,7]. The economic costs to LTCFs of an NG outbreak, including losses associated with suboptimal occupancy rates, care of infected patients, sick leave and overtime of staff, cleaning fees, etc., can be substantial [8][9][10][11].…”

Section: Introductionmentioning

confidence: 99%

Clinical pictures, treatments, and resource use of norovirus gastroenteritis in long-term care facilities: a survey with a chart review in Japan

2020

View full text Add to dashboard Cite

Background: Outbreaks of norovirus infection can have detrimental impacts on long-term care facilities. This study investigated the incidence, clinical picture, treatment and resource use of norovirus gastroenteritis in long-term care facilities. Methods: Nineteen facilities in Osaka and Kyoto, Japan participated in questionnaire surveys conducted between 2009 and 2011 regarding the incidence of norovirus gastroenteritis. From clinical charts, the characteristics, symptoms, and treatment of infected residents were analyzed. Total drug cost per infected resident was calculated by multiplying the unit price for each drug by the daily dose and the number of days administered and summing the costs for each drug (USD 1 = JPY 100). Results: Over the 3-year period, 8 outbreaks of norovirus gastroenteritis occurred in 6 facilities. The mean clinical course of 107 infected residents in five facilities that granted permission to examine patients' medical records was 4 days, with all but one resident presenting with vomiting and/or diarrhea, and 84 (79%) also presenting with associated symptoms. Of 107 infected residents, 72 (67%) were isolated. The proportion of infected residents isolated varied from 50 to 100% depending on the facility. Of the infected residents, 81 (76%) received some type of medication, the most common being infusion (67 patients, 63%) and antibiotics (30 patients, 28%). The median total cost of all drugs administered was USD 4.4, and the median drug cost per infected resident per day was USD 2.0. Total drug cost over the entire treatment period was the highest for antibiotics, at USD 8.6. Conclusion: Clinical course was similar to those of norovirus cases examined at other long-term care facilities. The majority of infected residents received some type of medication. Although the economic burden was not large, not a few infected residents were given antibiotics, which are ineffective for norovirus.

show abstract

Outbreak of G2P[4] rotavirus gastroenteritis in a retirement community, Brazil, 2015: An important public health risk?

Luchs

Madalosso²,

Cilli

et al. 2017

Geriatric Nursing

View full text Add to dashboard Cite

Direct costs associated with a hospital-acquired outbreak of rotaviral gastroenteritis infection in a long term care institution

Cited by 8 publications

References 18 publications

Cost analysis of a teaching hospital in Thailand: Impacts of the first wave of COVID-19

Cost analysis of a teaching hospital in Thailand: Impacts of the first wave of COVID-19

Clinical pictures, treatments, and resource use of norovirus gastroenteritis in long-term care facilities: a survey with a chart review in Japan

Outbreak of G2P[4] rotavirus gastroenteritis in a retirement community, Brazil, 2015: An important public health risk?

Contact Info

Product

Resources

About